Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2005
09/21/2005EP1575493A2 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005EP1220857B1 Gonadotropin releasing hormone receptor antagonists and their related methods of use
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671707A Novel process for producting imidazo[1, 2-b]pyridazine derivative
09/21/2005CN1671706A Modified pictet-spengler reaction and products prepared therefrom
09/21/2005CN1671705A Ligand and complex for catalytically bleaching a substrate
09/21/2005CN1671704A A method of preparing enantiomers of indole-2, 3-dione-3-oxime derivatives
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671697A Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671690A Antimicrobial aza-bicyclic derivates, their compositions and uses
09/21/2005CN1671667A Quinoline derivatives and their use as mycobacterial inhibitors
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1219780C Heterocyclic compounds binding chemotactic factor receptor
09/21/2005CN1219511C Method for curing sepsis
09/20/2005US6946478 Compounds
09/20/2005US6946473 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
09/20/2005US6946472 Polycyclic compounds exhibiting anti-tumor activities
09/20/2005US6946463 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain
09/20/2005US6946116 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
09/20/2005CA2188796C Heterocyclylbenzonitriles
09/20/2005CA2125978C Improvements in chemical compounds
09/20/2005CA2119757C New fluoro quinoline carboxylic-3 acid derivatives and their preparation
09/15/2005WO2005085249A1 Fused derivatives of pyrazole
09/15/2005WO2005085248A1 Heteroaryl-fused pyrazolo derivatives
09/15/2005WO2005085245A1 Pyrrolopyridine-2-carboxylic acid hydrazides
09/15/2005WO2005085244A1 3,5-disubstituted 1h-pzrrolo [2,3-b] pyridines as jnk inhibitors
09/15/2005WO2005085231A1 Novel 4-benzimidazol-2-ylpyridazin-3-one derivatives
09/15/2005WO2005085230A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
09/15/2005WO2005085228A1 Cycloalkanopyridine derivative
09/15/2005WO2005085225A1 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
09/15/2005WO2005085214A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005WO2005085209A1 Basic amine compound and use thereof
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005085196A2 Inhibitors of dna methylation in tumor cells
09/15/2005WO2005085194A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
09/15/2005WO2005068433A9 Benzimidazole derivatives
09/15/2005WO2005067502A3 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
09/15/2005WO2005065416A3 Process for the preparation of pyridopyrimidones
09/15/2005WO2005065050A3 Bicyclic compound
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005WO2005025504A3 Modulators of calcitonin and amylin activity
09/15/2005WO2005009389A3 Anaplastic lymphoma kinase modulators and methods of use
09/15/2005WO2005007672A3 Small molecule toll-like receptor (tlr) antagonists
09/15/2005WO2004073615A8 Deazaflavin compounds and methods of use thereof
09/15/2005WO2004018465A9 Benzonaphthyridines with pde 3/4 inhibiting activity
09/15/2005US20050203300 6-Alkoxy-pyrido-pyrimidines
09/15/2005US20050203156 Hydantoins having RNase modulatory activity
09/15/2005US20050203146 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
09/15/2005US20050203128 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
09/15/2005US20050203126 Inhibitors of basic fibroblast growth factors (FGFs); treating cancer, rheumatoid arthritis, inflammatory bowel disease, cardiovascular disorders, diabetic retinopathy, achondroplasia, hypochondoplasia, or thanathophoric dysplasia
09/15/2005US20050203124 Compounds for the sustained reduction of body weight
09/15/2005US20050203119 Dihydropyridine compounds for treating or preventing metabolic disorders
09/15/2005US20050203118 Rheumatic diseases; antiarthritic agents; multiple sclerosis; antidiabetic agents; asthma therapy; skin disorders
09/15/2005US20050203110 KINESIN SPINDLE PROTEIN INHIBITOR; ANTIPROLIFERATIVE AGENTS; ANTICANCER AGENTS; 4-(2,5-DIFLUOROPHENYL)-n-3 -FLUOROPYRROLIDIN-3-YL-2-HYDROXYMETHYL-2-PHENYL-2,5-DIHYDRO-1n-PYRROL-1-CARBOXAMIDE
09/15/2005US20050203109 Novel Compounds
09/15/2005US20050203101 Benzimidazole quinolinones and uses thereof
09/15/2005US20050203094 Thromboembolic disorders; anticoagulants; e.g. 2-[5'-fluoro-2,2'-dihydroxy-5-(2-oxo-tetrahydro-furan-3-yl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine
09/15/2005US20050203091 Heteroaryl-fused pyrazolo derivatives and methods for using the same
09/15/2005US20050203084 Protease inhibitors
09/15/2005US20050203080 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
09/15/2005US20050203078 Inhibitors of factor Xa or related serine proteases; thrombosis; benzamide derivatives with benzimidazole, indole or imidazo(1,2-a)pyridine rings; e.g. 4-(azepan-2-on-1-yl)-N-[(1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethyl]-3-methyl-benzamide
09/15/2005US20050202076 Stabilization, homogenizing, sterile filtration, dehydration, reconstitution, ultrafiltration; storage stability; taxanes
09/15/2005DE102004010207A1 New 4-benzimidazolyl-3(2H)-pyridazinone derivatives are kinase inhibitors, especially useful for treatment of cancer
09/15/2005DE102004004972B3 Heterocyclisch substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Heterocyclic-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, to processes for their preparation and their use as medicaments
09/15/2005DE102004004971B3 Cycloalkyl substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arnzeimittel Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, to processes for their preparation and their use as Arnzeimittel
09/15/2005CA2820541A1 Caspase inhibitors and uses thereof
09/15/2005CA2558600A1 A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
09/15/2005CA2558278A1 Diaryl-substituted five-membered heterocycle derivative
09/15/2005CA2558274A1 Cycloalkanopyridine derivative
09/15/2005CA2558109A1 Heteroaryl-fused pyrazolo derivatives
09/15/2005CA2557581A1 Inhibitors of dna methylation in tumor cells
09/15/2005CA2557575A1 Fused derivatives of pyrazole
09/15/2005CA2555161A1 Novel 4-benzimidazol-2-yl-pyridazin-3-one derivatives
09/14/2005EP1574499A1 Inhibitors of DNA methylation in tumor cells
09/14/2005EP1572693A1 Mitogen activated protein kinase-activated protein kinase-2 inhibiting compounds
09/14/2005EP1572692A1 Enantiomer (-) of tenatoprazole and the therapeutic use thereof
09/14/2005EP1572691A1 Pyrazole compounds as integrin receptor antagonists derivatives
09/14/2005EP1572690A1 Thiazole compounds as integrin receptor antagonists derivatives
09/14/2005EP1572689A1 Tetracyclic immunomodulatory compounds
09/14/2005EP1572682A2 Acyclic pyrazole compounds for the inhibition of mitogen activated protein kinase-activated protein kinase-2
09/14/2005EP1572678A2 Substituted n-phenyl sulfonamide bradykinin antagonists
09/14/2005EP1572662A1 Pyrazole and imidazole compounds and uses thereof
09/14/2005EP1572659A2 The use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinence
09/14/2005EP1572657A1 Processes for preparing quinolonecarboxylate derivatives
09/14/2005EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia
09/14/2005EP1572215A1 Benzo[d]azepine derivatives for the treatment of neurological disorders
09/14/2005EP1572209A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
09/14/2005EP1572113A2 Calcium receptor modulating compound and use thereof
09/14/2005EP1341781B1 Antimicrobial quinolones
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1259509B1 Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo 1,2-a]pyridine-3-(n,n-dimethyl-acetamide) and intermediates
09/14/2005EP1258250B1 Nerve protective drugs
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1668708A Oxidation process for preparing quinacridone pigments
1 ... 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 ... 646